Inventor

Muhammad Altaf

Inventor

Dhahran, SA

Overview

38→

Patents

2016–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 38 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Fprimary

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium31%

A61KPreparations for medical, dental or toiletry purposes28%

G01NInvestigating or analysing materials by determining their chemical or physical properties11%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms10%

A61NElectrotherapy7%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%

C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds3%

A61BDiagnosis2%

G06FElectric digital data processing1%

G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data1%

PatentTitleYear

10,562,928Pharmaceutical composition containing a cisplatin and platinum thiocyanate combination2020 10,538,544Method for administering cisplatin and a thiocyanate complex to treat ovarian cancer2020 10,533,029Anticancer trans-diaminoplatinum(II) complexes of selenones2020 10,494,392Method of treating cancer with a two-component anti-cancer composition2019 10,494,391Two-component anti-cancer composition2019 10,494,394Synthesis, x-ray structures and cytotoxic behavior of platinum (II) complexes of dithiocarbamates2019 10,385,072Gold(III) complexes as anticancer agents and a method of treating cancer2019 10,358,456Platinum(II) complexes with selone ligands and method of use2019 10,336,779Gold(I) complexes, pharmaceutical compositions thereof, and methods of treating cancer2019 10,327,691Systems and method for detecting, diagnosing, and/or treatment of disorders and conditions2019 10,301,335Gold complex-containing cancer activity composition2019 10,294,254DNA/Dithiocarbamato phosphine metal complex2019 10,280,187Mononucleotide-dithiocarbamate complex2019 10,273,257Cancer cell-containing composition2019 10,189,865Gold(I) complexes, pharmaceutical compositions thereof, and methods of treating proliferative disorders2019 10,172,823Method for inhibiting cancer cell growth with a transplatin complex2019 10,160,773Method for inducing cytotoxicity in cancer cells2018 10,144,749Gold complexes of alkylated phosphines2018 10,093,689Composition containing a gold (I) complex and cancer cells2018 10,092,579Gold(I) complexes with anticancer properties and methods of use thereof2018 10,077,280Mixed ligand gold(I) complexes as anti-cancer agents2018 9,994,592Anticancer activity of gold(III) complexes of meso-1,2-di(1-naphthyl)-1,2-diaminoethane2018 9,974,765Transplatin derivatives as anticancer agents2018 9,880,170'Gluthatione/gold(III) pharmaceutical composition'2018 9,848,793Machine-based patient-specific seizure classification system2017 9,840,528'Thione-platinum(II) complexes and pharmaceutical compositions thereof'2017 9,796,734'Gold(III) anti-cancer agents'2017 9,782,380'Method for treating ovarian cancer and/or Hodgkin lymphomia with a gold(III) complex'2017 9,657,035'Method of treating cancer and gold(III) complexes as anti-cancer agents'2017 9,649,292'Method for treating prostate cancer and/or gastrointestinal cancer'2017 9,585,861'Method for treating a cancer with a mixed ligand gold(III) complexes as anti-cancer agents'2017 9,572,822'Treatment of cervical cancer with gold(I) complexes'2017 9,573,967'N-heterocyclic carbene gold complexes with anticancer properties and methods of use thereof'2017 9,561,237'Bis-(triethylphosphine)platinum(II) complexes with thiones as anti cancer agents'2017 9,492,465'Gold(I) complexes with t-butyl phosphine and dialkyl dithiocarbamate ligands'2016 9,487,542'Mixed ligand gold(III) complexes and methods thereof'2016 9,481,699'Platinum(II) complexes with thione ligands and methods thereof'2016 9,481,693'Mixed ligand gold(III) complexes as anti-cancer agents'2016

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2016–2020Patents assigned to UNIV KING FAHD PET & MINERALS (36)· patent assignee history

2016–2017Patents assigned to KING ABDULAZIZ CITY SCI & TECH (2)· patent assignee history

2016–2020Based in Dhahran, SA· patent location history

2017Patents assigned to MASDAR INSTITUTE OF SCIENCE AND TECH (1)· patent assignee history

2017–2019Based in Abu Dhabi, AE· patent location history

2018–2019Patents assigned to UNIV KING SAUD (8)· patent assignee history

2019Patents assigned to UNIV KHALIFA SCIENCE & TECHNOLOGY (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
UNIV KING FAHD PET & MINERALS	36	2016–2020
UNIV KING SAUD	8	2018–2019
KING ABDULAZIZ CITY SCI & TECH	2	2016–2017
MASDAR INSTITUTE OF SCIENCE AND TECH	1	2017
UNIV KHALIFA SCIENCE & TECHNOLOGY	1	2019

Locations

Location	Patents	Span
Dhahran, SA	36	2016–2020
Abu Dhabi, AE	2	2017–2019